CS218511B1 - Method of making the 2-/substituted phenyl/propionaldehyde - Google Patents
Method of making the 2-/substituted phenyl/propionaldehyde Download PDFInfo
- Publication number
- CS218511B1 CS218511B1 CS636381A CS636381A CS218511B1 CS 218511 B1 CS218511 B1 CS 218511B1 CS 636381 A CS636381 A CS 636381A CS 636381 A CS636381 A CS 636381A CS 218511 B1 CS218511 B1 CS 218511B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- defined above
- hydrogen
- process according
- phase
- Prior art date
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title description 5
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 title description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000012074 organic phase Substances 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- -1 2- (substituted phenyl) propionaldehydes Chemical class 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 150000008062 acetophenones Chemical class 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 238000006114 decarboxylation reaction Methods 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 claims description 3
- 239000003444 phase transfer catalyst Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000002431 hydrogen Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- RSHIVZARDAPEDE-UHFFFAOYSA-N oxirane-2-carbonitrile Chemical compound N#CC1CO1 RSHIVZARDAPEDE-UHFFFAOYSA-N 0.000 claims description 2
- 239000012071 phase Substances 0.000 claims description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- 150000007522 mineralic acids Chemical class 0.000 claims 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 101150046432 Tril gene Proteins 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims 1
- 239000000920 calcium hydroxide Substances 0.000 claims 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 230000020477 pH reduction Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- QCAMDQRKWIVWKA-UHFFFAOYSA-N 3-methyl-3-phenyloxirane-2-carbonitrile Chemical compound C=1C=CC=CC=1C1(C)OC1C#N QCAMDQRKWIVWKA-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000003476 Darzens condensation reaction Methods 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- XZWYAMYRMMMHKM-UHFFFAOYSA-N 1-(2-phenylphenyl)ethanone Chemical group CC(=O)C1=CC=CC=C1C1=CC=CC=C1 XZWYAMYRMMMHKM-UHFFFAOYSA-N 0.000 description 1
- HCEKGPAHZCYRBZ-UHFFFAOYSA-N 1-(3-fluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1 HCEKGPAHZCYRBZ-UHFFFAOYSA-N 0.000 description 1
- KEAGRYYGYWZVPC-UHFFFAOYSA-N 1-[4-(2-methylpropyl)phenyl]ethanone Chemical compound CC(C)CC1=CC=C(C(C)=O)C=C1 KEAGRYYGYWZVPC-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- DMZVZANOMJGHKO-UHFFFAOYSA-N 2-[4-(2-methylpropyl)phenyl]propanal Chemical compound CC(C)CC1=CC=C(C(C)C=O)C=C1 DMZVZANOMJGHKO-UHFFFAOYSA-N 0.000 description 1
- IQVAERDLDAZARL-UHFFFAOYSA-N 2-phenylpropanal Chemical compound O=CC(C)C1=CC=CC=C1 IQVAERDLDAZARL-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- OTGHWLKHGCENJV-UHFFFAOYSA-N glycidic acid Chemical class OC(=O)C1CO1 OTGHWLKHGCENJV-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical class OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 150000004672 propanoic acids Chemical class 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- ZFNVDHOSLNRHNN-UHFFFAOYSA-N xi-3-(4-Isopropylphenyl)-2-methylpropanal Chemical compound O=CC(C)CC1=CC=C(C(C)C)C=C1 ZFNVDHOSLNRHNN-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
(54) Způsob výroby 2-(substituovaných fenyl Jpropion aldehydů(54) A process for the preparation of 2- (substituted phenyl) propionic aldehydes
Vynález se týká způsobu výroby 2-(substituovaných fenyl Jpropion,aldehydů obecné-The present invention relates to a process for the preparation of 2- (substituted phenyl) propionic aldehydes.
kde R značí vodík nebo alkyl s 1 až 5 atomy uhlíku nebo skupinu obecného vzorce Ia,wherein R is hydrogen or (C 1 -C 5) alkyl or a group of formula (Ia),
(taj kde R1 značí vodík nebo alkyl s 1 ,až 3 atomy uhlíku nebo atom halogenu, jako fluor, chl-dr nebo triflu-ormethylovou skupinu, X značí vodík, fluor, chlor nebo trifluormethylovou skupinu.(wherein R @ 1 denotes hydrogen or alkyl having 1 to 3 carbon atoms or a halogen atom such as fluorine, chlorine or trifluoromethyl, X denotes hydrogen, fluorine, chlorine or trifluoromethyl.
Uvedená skupina látek obecného vzorce I tvoří významnou skupinu meziproduktů, které slouží k přípravě derivátů 2-fenylpropio2 nové kyseliny. Tyto kyseliny Jsou významnými léčivy v humánní medicíně (Nátuře 181, 773 [1958]} s protizánětlivými účinky při zánětech kloubů a jejich okolí. Analogické protizánětlivé, analgetické a antipyretické účinky, vyšší než deriváty kyseliny salicylové, vykazují i látky obecného vzorce I.This group of compounds of formula (I) is an important group of intermediates used to prepare 2-phenylpropionic acid derivatives. These acids are important drugs in human medicine (Nature 181, 773 [1958]} with anti-inflammatory effects in and around the joint inflammation. Analogous anti-inflammatory, analgesic and antipyretic effects, higher than salicylic acid derivatives, also show compounds of formula I.
Dopos-ud známé způsoby výroby a přípravy látek obecného vzorce I využívají Darzensovy kondenzace [viz Čs. pat. spisy 140 226, Chem. Rev. 55, 283 (1955), Organic Reactions Vol. V. str. 413 (1957), Methoden der Organischen Chemie (Houben-Weyl) díl 7/1, str. 326 (1954)], to je reakce substituovaného» acetofenonu s chloroctanem ethylnatým v inertní atmosféře a přítomnosti silně bazických činidel. Tímto způsobem připravený glycidoester A,The hitherto known processes for the preparation and preparation of the compounds of formula I utilize Darzens condensation [cf. U.S. Pat. No. 140,226, Chem. Roar. 55, 283 (1955), Organic Reactions Vol. P. 413 (1957), Methoden der Organischen Chemie (Houben-Weyl) vol. 7/1, p. 326 (1954)], i.e. the reaction of substituted acetophenone with ethyl chloroacetate in an inert atmosphere and in the presence of strongly basic reagents. The glycidoester A prepared in this way,
OO
ZIZI
Ar—C—CHCOOC2H5 ,Ar — C — CHCOOC2 H5,
CHs (A) kde Ar značí substituovaný fenylový zbytek, po hydrolýze a dékarboxylaci poskytne žádaný aldehyd B,CHs (A) wherein Ar is a substituted phenyl moiety, upon hydrolysis and decarboxylation, affords the desired aldehyde B,
Ar—CH—CHOAr — CH — CHO
IAND
CH3 ;_ (B).CH 3; (B).
i kde Ar má shora uvedený význam.wherein Ar is as defined above.
Tento postup výroby aldehydů má řadu nevýhod. Reakci je nutné provádět v absolutizovaných rozpouštědlech v inertní atmosféře za použití nebezpečných reagencií jako sodíku, natriumhydridu nebo natriumamidu. Získávání čistého glycidoesiteru z reíaikoní směsi po Darzensově kondenzaci je obtížné. Je třeba vždy oddělit nezreagovaný výchozí substituovaný acetofenon a některé vedlejší nežádoucí látky vzniklé při reakci.This process for producing aldehydes has a number of disadvantages. The reaction must be carried out in absolute solvents in an inert atmosphere using hazardous reagents such as sodium, sodium hydride or sodium amide. Obtaining pure glycido ester from the re-conicion mixture after Darzens condensation is difficult. It is always necessary to separate the unreacted starting substituted acetophenone and some of the undesirable by-products of the reaction.
Na tyto postupy navazuje způsob podle vynálezu, kteirý doposud známé nevýhody odstraňuje. Předmětem vynálezu je způsob výroby 2-subatifuováných fenyl) propionaldehydů obecného vzorce I, který spočívá v ítom, že se na substituovaný acetofenon obecného vzorce II,These processes are followed by a process according to the invention which eliminates the known disadvantages. SUMMARY OF THE INVENTION The present invention provides a process for the preparation of 2-subatified phenyl) propionaldehydes of formula (I), which process comprises:
(II) kde R a X mají shora uvedený význam, působí chlorucetonitrilem v silně alkalickém prostředí v dvoufázovém systému vodná fáze—organická fáze za přítomnosti katalyzátoru fázového přenosu při teplotě 25 až 70° Celsia. Získaný glycidonitril obecného vzorce III,(II) wherein R and X are as defined above, in a strongly alkaline environment, chloroacetonitrile acts in a two-phase aqueous phase-organic phase system in the presence of a phase transfer catalyst at 25 to 70 ° C. The glycidonitrile of formula III obtained,
kde R a X mají shora uvedený význam, se ihydrolyzuje roztokem hydroxidu ve vodné alkoholickém prostředí na sůl glycldokyseliny obecného vzorce IV,wherein R and X are as defined above, ihydrolyzed with a solution of hydroxide in an aqueous alcoholic medium to form the glycidic acid salt of formula IV,
kde R a X mají shora uvedený význam a M značí kov ze skupiny alkalických kovů nebo alkalických zemin. Po uvolnění kyseliny a následující dekarboxylaci se získá žádaný aldehyd obecného vzorce I.wherein R and X are as defined above and M is an alkali metal or alkaline earth metal. Upon liberation of the acid and subsequent decarboxylation, the desired aldehyde of formula I is obtained.
Výhodou podle vynálezu je jednoduché provedení reakce, levná činidla a snadnéThe advantage of the invention is that it is simple to carry out the reaction, cheap reagents and easy
Zpracování reakční směsí. Tímto postupem připravené aldehydy se jednoduše izolují destilací nebo krystalizaci v dostatečně čisté formě k přípravě substituovaných propionových kyselin.Treatment with reaction mixture. The aldehydes prepared in this way are simply isolated by distillation or crystallization in sufficiently pure form to prepare substituted propionic acids.
Způsob podle vynálezu je demonstrován na několika příkladech.The method of the invention is demonstrated in several examples.
Příklad 1Example 1
2-fenyl-3-kyan-2-methyloxiran (III, R = Η, X = H)2-Phenyl-3-cyano-2-methyloxirane (III, R = Η, X = H)
Ke směsi 13,2 g acetofenonu, 20 ml 50% louhu sodného, 0,g g benzyltrlethylamoniumchloridu ve 30 ml benzenu bylo po kapkách za intenzivního míchání přidáno 8,4 g chloracetonitrilu během 15 minut při teplotě 10 až 20 °C. Po dalších 30 minutách míchání při této teplotě byla organická fáze oddělena a vodná extrahována 2krát 10 ml benzenu. Spojené organické podíly byly promyty vodou (10 mlj, vysušeny síranem hořečnatým a rozpouštědla oddestilována. Destilací zbytku bylo získáno 11,2 g produktu vzorce III, t. v. 133 až 137 °C při 2,13 kPa. Spektrální charakteristiky jsou v souhlase s navrženou strukturou.To a mixture of 13.2 g of acetophenone, 20 ml of 50% sodium hydroxide solution, 0.1 g of benzyltrlethylammonium chloride in 30 ml of benzene was added dropwise with vigorous stirring 8.4 g of chloroacetonitrile over 15 minutes at 10 to 20 ° C. After stirring for another 30 minutes at this temperature, the organic phase was separated and the aqueous extracted twice with 10 ml of benzene. The combined organics were washed with water (10 mL), dried over magnesium sulfate and the solvents were distilled off. Distillation of the residue gave 11.2 g of the product of formula III, bp 133-137 ° C at 2.13 kPa. The spectral characteristics were consistent with the proposed structure.
Příklad 2Example 2
2-fenylpropionaldehyd (I, R = X = H)2-Phenylpropionaldehyde (I, R = X = H)
Směs 9,51 g 2-fenyl-3-kyan-2-methyloxiranu, 50 ml 10% louhu sodného a 60 ml ethanolu byla zahřívána k varu 10 hodin (do ukončení vývoje amoniaku). Potom byla rozpouštědla odpařena na rotační vakuové odparce a k pevnému zbytku bylo přidáno 30 ml směsi ethanol—ether (1:1), sůl kyseliny odsáta, rozpuštěna v 25 ml vody a po okyselení 10 ml konc. kyseliny solné byla směs zahřívána na vroucí vodní lázni 1,5 hodiny. Po ochlazení vyloučená olejová vrstva byla oddělena a vodná fáze extrahována 2'krát 10 ml benzenu. Organické vrstvy byly po spojení promyty vodou (5 ml), vysušeny síranem hořečnatým a rozpouštědla odpařena. Frakcionací zbytku bylo získáno 6,1 g produktu t. v. 86 až 87 °C při 2,13 kPa, jehož spektrální charakteristiky jsou v souhlase s navrlženou strukturou. Pomočí plynové chromatografie bylo zjištěno, že produkt obsahuje 98,8 % látky.A mixture of 9.51 g of 2-phenyl-3-cyano-2-methyloxirane, 50 ml of 10% sodium hydroxide solution and 60 ml of ethanol was heated at reflux for 10 hours (until complete ammonia evolution). The solvents were then removed by rotary evaporation and 30 ml of ethanol-ether (1: 1) was added to the solid residue, the acid salt was filtered off with suction, dissolved in 25 ml of water and acidified with 10 ml of conc. hydrochloric acid was heated in a boiling water bath for 1.5 hours. After cooling, the precipitated oil layer was separated and the aqueous phase was extracted 2 times with 10 ml of benzene. The combined organic layers were washed with water (5 mL), dried (MgSO 4) and the solvents evaporated. Fractionation of the residue yielded 6.1 g of product, m.p. 86-87 ° C at 2.13 kPa, the spectral characteristics of which were consistent with the proposed structure. The product was found to be 98.8% by gas chromatography.
Příklad 3Example 3
2- (4-isoibuty lfenyl )-3-kyan-2-methyloxiran [III, R = (CH3)2tCHCH2; X = H]2- (4-isoibutylphenyl) -3-cyano-2-methyloxirane [III, R = (CH3) 2 ] CH2CH2; X = H]
Ke směsi 40,9 g 4-isobutylacetofenonu, 1,2 gramu benzaltriethylamoniumchloridu, 40 ml 50% louhu sodného a 50 ml benzenu bylo za míchání přidáno 16,7 g chloracetonitrilu při teplotě reakční směsi 10 až 15 O.To a mixture of 40.9 g of 4-isobutylacetophenone, 1.2 g of benzaltriethylammonium chloride, 40 ml of 50% sodium hydroxide solution and 50 ml of benzene was added, with stirring, 16.7 g of chloroacetonitrile at a reaction temperature of 10-15 ° C.
218311218311
SWITH
Po analogickém zpracování jako v příkladu 1 bylo· po frakcionaci na koloně získáno 29,5 g produktů t. v. 120 až 125 *C při tlaku 93 Pa. Struktura látky byla potvrzena pomocí hmotnostního a infračerveného spektra.After analogous work-up as in Example 1, 29.5 g of b.p. 120-125 ° C were obtained after column fractionation at a pressure of 93 Pa. The structure of the substance was confirmed by mass and infrared spectra.
Příklad 4Example 4
2.-.( 4-Wfenylyl )-3-kyan-2-methyloxiran (III, R = CeHs; X = II) '2.- (4-Phenylyl) -3-cyano-2-methyloxirane (III, R = C 6 H 5; X = II)
Kě směsi 14,3 g acetylbifenylu, 14 ml 50% louhu sodného, 0,3 g methyltrioktylamoniumchlorídu, 30 ml benzénu a 7 ml acetonitrilu byla za intenzivního míchání při teplotě reakční sihěsi přidáno 6,1 g chloraeetonitrilu během 25 minut. Po dalších 40 minutách míchání při této teplotě byla reakční směs zpracována jako v příkladu 1. Krystaíizací zbytku bylo získáno 12,6 g produktu t. t. 72 až 94 °C ( směs geometrických isomerů). Tuto směs se podařilo rozdělit pomocí chromatografie na sloupci silikagelu na isomer s t. t. 104 až 105 °C a na isomer t. t. 86,5 až 88,0 °C. Spektrální charakteristiky jsou v souhlase s navrženou strukturou.To a mixture of 14.3 g of acetylbiphenyl, 14 ml of 50% sodium hydroxide solution, 0.3 g of methyltrioctylammonium chloride, 30 ml of benzene and 7 ml of acetonitrile was added 6.1 g of chloroacetonitrile with vigorous stirring at the reaction temperature over 25 minutes. After stirring for another 40 minutes at this temperature, the reaction mixture was worked up as in Example 1. Crystallization of the residue yielded 12.6 g of the product, mp 72-94 ° C (mixture of geometric isomers). This mixture was separated by silica gel column chromatography to give an isomer of m.p. 104-105 ° C and an isomer of mp 86.5-88.0 ° C. The spectral characteristics are in accordance with the proposed structure.
Příklad 5Example 5
2- (4-isobutylfenyl) pr opionaldehyd [I; R = (CHs)zCHCH2, X = HJ2- (4-isobutylphenyl) propionaldehyde [I; R = (CH3) 2 CHCH2, X = HJ
K 12,4 g oxiramu III, R = (CH3)2CHCH2, X = H, bylo přidáno 50 ml 10% louhu sodného, 60 ml ethanolu a reakční směs zahřívána 12 hodin k varu. Po analogickém zpracování jako v příkladu 2 bylo frakcionaci získáno· 6,25 g produktu t. v. 85 až 87 °C při 93 Pa, který obsahuje podle chromatografie plynové 98,4 % látky. Hmotnostní spektrum je v souhlase s navrženou strukturou.To 12.4 g of oxiram III, R = (CH 3) 2 CHCH 2, X = H, 50 ml of 10% sodium hydroxide solution, 60 ml of ethanol were added and the reaction mixture was heated at reflux for 12 hours. After analogous work-up as in Example 2, fractionation yielded 6.25 g of the product, m.p. 85-87 ° C at 93 Pa. The mass spectrum is in accordance with the proposed structure.
Příklad 6Example 6
2-(3-f luoirf enyl )-3-kyan-2-methyloxiran (III; R = Η, X = F) .2- (3-fluoro-phenyl) -3-cyano-2-methyloxirane (III; R = Η, X = F).
Ke směsi 15,2 g 3-fluoracetofenůnu (t. v. 80 až 82 °C/1,2 kPa), 20 ml 50% louhu sodného, 0,5 g trioktylmethylamonium chloridu ve 30 ml toluenu bylo po- kapkách za intensivního míohání přidáno 8,6 g chlotacetonitrilu při teplotě reakční směsi 10 až 15° Celsia. Potom bylo pokračováno jako v příkladu 1. Destilací bylo získáno 12,5 g produktu t. v. 140 až 143 °C/2,1 kPa, jehož struktura je v souhlase se spektrálními údaji.To a mixture of 15.2 g of 3-fluoroacetophenone (to 80-82 ° C / 1.2 kPa), 20 ml of 50% sodium hydroxide solution, 0.5 g of trioctylmethylammonium chloride in 30 ml of toluene, was added dropwise with vigorous stirring, 6 g of Chloroacetonitrile at a reaction mixture temperature of 10-15 ° C. It was then continued as in Example 1. Distillation yielded 12.5 g of product, m.p.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS636381A CS218511B1 (en) | 1981-08-26 | 1981-08-26 | Method of making the 2-/substituted phenyl/propionaldehyde |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS636381A CS218511B1 (en) | 1981-08-26 | 1981-08-26 | Method of making the 2-/substituted phenyl/propionaldehyde |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS218511B1 true CS218511B1 (en) | 1983-02-25 |
Family
ID=5410480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS636381A CS218511B1 (en) | 1981-08-26 | 1981-08-26 | Method of making the 2-/substituted phenyl/propionaldehyde |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS218511B1 (en) |
-
1981
- 1981-08-26 CS CS636381A patent/CS218511B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6702623B2 (en) | Method for preparing compounds such as 3-arylbutanal useful in the synthesis of medetomidine | |
| CA1090811A (en) | .alpha.-THIO-ALKANOIC ACID DERIVATIVES | |
| JP2955283B2 (en) | Tri-substituted benzoic acid intermediate | |
| CS218511B1 (en) | Method of making the 2-/substituted phenyl/propionaldehyde | |
| GB2081714A (en) | Cyclohexylcarboxylic acid derivatives | |
| US4393008A (en) | 2-Cyano-2-(3-phenoxy-phenyl)-propionic acid amide and preparation thereof | |
| JPS59104347A (en) | Manufacture of arylalkanoic acid ester | |
| US3803245A (en) | Process for preparing 2-(6-methoxy-2-naphthyl)propionic acid,and intermediate therefor | |
| US4007217A (en) | Process for producing 2-hydroxy-3-butenoic acid derivatives | |
| FI66833C (en) | FOERFARANDE OCH MELLANPRODUKT FOER FRAMSTAELLNING AV FENYLALKYLKARBOXYLSYRADERIVAT | |
| US5543531A (en) | Thiophen compounds and their preparation | |
| EP0220025B1 (en) | 3-perfluoroalkyl-5-hydroxyisoxazoles | |
| NO139782B (en) | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 3-BENZOYLPHENYLACIC ACID OR 2- (3-BENZOYLPHENYL) PROPHIC ACID | |
| JP2830210B2 (en) | Synthesis of α, β-unsaturated ketones | |
| EP0296463B1 (en) | Thiophen compounds and their preparation | |
| US9611217B2 (en) | Synthetic processes of carprofen | |
| JP2801647B2 (en) | Method for producing 6-fluorochromone-2-carboxylic acid derivative | |
| US4013692A (en) | Certain 3-phenyl-benzofuran lower alkanoic acids and esters thereof | |
| JPS59110649A (en) | Manufacture of alpha-vinylpropionic acid ester | |
| HU202179B (en) | Process for producing halogenated 3,3-dimethyl-5-hexen-2-one derivatives | |
| CS219752B1 (en) | Method of making the derivative of the 2-phenylpropione acid | |
| JPS62234077A (en) | Method for producing γ-butyrolactones | |
| WO1993013060A1 (en) | Novel intermediate compound and production thereof | |
| FI62049C (en) | FOERFARANDE FOER FRAMSTAELLNING AV INDANDERIVAT | |
| KR860000173B1 (en) | Process for preparing alpha-aromatic group substituted alkanoic acids or esters thereof |